Working with patients and their carers to develop a resource use measure for diabetic foot ulcers – the REDUCE trial.

Key contact:
Dr Llinos Haf Spencer, CHEME, Bangor University, 

What was the question that HCEC could help with?

Diabetic foot ulcers were estimated to cost the NHS almost £1 billion in 2014/15. The NIHR Reducing the Impact of Diabetic Foot Ulcers (REDUCE) trial evaluates an intervention enabling patients with diabetes to monitor changes in their feet, maintain safe levels of physical activity, seek early access to medical help and manage their mood.

What did we do? 

Patients are the experts on their own health and an
important source of information on the use of healthcare and other resources required for health economic evaluations. However, generic outcome measures do not always capture all the data that is important to a specific patient group. HCEC researchers at SCHE worked with people suffering from diabetic foot ulcers, their carers, and the healthcare professionals treating them to develop a
resource use measure for the REDUCE trial that will be able to pick up on the parameters that are important to patients and will result in the best outcomes.


What was the impact?

The resource use measure, co-produced with patients and their carers will provide comprehensive data for the health economic evaluation, improving the quality and relevance of our work. The final version is currently being used in the main REDUCE trial and the results will inform the economic evaluation. The measure will be made available to other researchers. The REDUCE award (RP-PG-0618-20001) is
registered on the NIHR portfolio.